AQST Annual Short Term Debt
$412.00 K
-$18.54 M-97.83%
31 December 2023
Summary:
As of January 23, 2025, AQST annual short term debt is $412.00 thousand, with the most recent change of -$18.54 million (-97.83%) on December 31, 2023. During the last 3 years, it has fallen by -$2.89 million (-87.53%). AQST annual short term debt is now -97.83% below its all-time high of $18.95 million, reached on December 31, 2022.AQST Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AQST Quarterly Short Term Debt
$507.00 K
+$28.00 K+5.85%
30 September 2024
Summary:
As of January 23, 2025, AQST quarterly short term debt is $507.00 thousand, with the most recent change of +$28.00 thousand (+5.85%) on September 30, 2024. Over the past year, it has dropped by -$4.47 million (-89.80%). AQST quarterly short term debt is now -97.33% below its all-time high of $18.95 million, reached on December 31, 2022.AQST Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AQST Short Term Debt Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -97.8% | -89.8% |
3 y3 years | -87.5% | -89.8% |
5 y5 years | -91.0% | -89.8% |
AQST Short Term Debt High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -97.8% | at low | -97.3% | +23.1% |
5 y | 5-year | -97.8% | -97.3% | ||
alltime | all time | -97.8% | -97.3% |
Aquestive Therapeutics Short Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $507.00 K(+5.8%) |
June 2024 | - | $479.00 K(+9.6%) |
Mar 2024 | - | $437.00 K(+6.1%) |
Dec 2023 | $412.00 K(-97.8%) | $412.00 K(-91.7%) |
Sept 2023 | - | $4.97 M(-73.4%) |
June 2023 | - | $18.71 M(+6.8%) |
Mar 2023 | - | $17.52 M(-7.6%) |
Dec 2022 | $18.95 M(+548.3%) | $18.95 M(+25.8%) |
Sept 2022 | - | $15.07 M(+41.3%) |
June 2022 | - | $10.66 M(+42.4%) |
Mar 2022 | - | $7.49 M(+156.1%) |
Dec 2021 | $2.92 M | $2.92 M(-65.9%) |
Sept 2021 | - | $8.59 M(+43.7%) |
Date | Annual | Quarterly |
---|---|---|
June 2021 | - | $5.97 M(+28.5%) |
Mar 2021 | - | $4.65 M(+40.8%) |
Dec 2020 | $3.30 M(>+9900.0%) | $3.30 M(+36.8%) |
Sept 2020 | - | $2.41 M(+250.4%) |
June 2020 | - | $689.00 K(+13.1%) |
Mar 2020 | - | $609.00 K(>+9900.0%) |
Dec 2019 | $0.00(-100.0%) | $0.00(-100.0%) |
June 2019 | - | $550.00 K(-92.0%) |
Mar 2019 | - | $6.85 M(+48.9%) |
Dec 2018 | $4.60 M | $4.60 M(+67.3%) |
Sept 2018 | - | $2.75 M(+150.0%) |
June 2018 | - | $1.10 M(-33.3%) |
Mar 2018 | - | $1.65 M |
FAQ
- What is Aquestive Therapeutics annual short term debt?
- What is the all time high annual short term debt for Aquestive Therapeutics?
- What is Aquestive Therapeutics annual short term debt year-on-year change?
- What is Aquestive Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Aquestive Therapeutics?
- What is Aquestive Therapeutics quarterly short term debt year-on-year change?
What is Aquestive Therapeutics annual short term debt?
The current annual short term debt of AQST is $412.00 K
What is the all time high annual short term debt for Aquestive Therapeutics?
Aquestive Therapeutics all-time high annual short term debt is $18.95 M
What is Aquestive Therapeutics annual short term debt year-on-year change?
Over the past year, AQST annual short term debt has changed by -$18.54 M (-97.83%)
What is Aquestive Therapeutics quarterly short term debt?
The current quarterly short term debt of AQST is $507.00 K
What is the all time high quarterly short term debt for Aquestive Therapeutics?
Aquestive Therapeutics all-time high quarterly short term debt is $18.95 M
What is Aquestive Therapeutics quarterly short term debt year-on-year change?
Over the past year, AQST quarterly short term debt has changed by -$4.47 M (-89.80%)